These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12383006)

  • 21. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.
    Hinschberger A; Butt S; Lelong V; Boulouard M; Dumuis A; Dauphin F; Bureau R; Pfeiffer B; Renard P; Rault S
    J Med Chem; 2003 Jan; 46(1):138-47. PubMed ID: 12502367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
    Vyas VK; Gupta N; Ghate M; Patel S
    SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.
    López-Rodríguez ML; Morcillo MJ; Benhamú B; Rosado ML
    J Comput Aided Mol Des; 1997 Nov; 11(6):589-99. PubMed ID: 9491351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
    Babu S; Sohn H; Madhavan T
    Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and Activity of Membrane Receptors: Modeling and Computational Simulation of Ligand Recognition in a Three-Dimensional Model of the 5-Hydroxytryptamine(1A) Receptor.
    Pardo L; Batlle M; Duñach M; Weinstein H
    J Biomed Sci; 1996 Apr; 3(2):98-107. PubMed ID: 11725090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New arylpiperazine derivatives as antagonists of the human cloned 5-HT(4) receptor isoforms.
    Curtet S; Soulier JL; Zahradnik I; Giner M; Berque-Bestel I; Mialet J; Lezoualc'h F; Donzeau-Gouge P; Sicsic S; Fischmeister R; Langlois M
    J Med Chem; 2000 Oct; 43(20):3761-9. PubMed ID: 11020291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D QSAR studies on substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist.
    Vyas VK; Ghate M; Chintha C; Patel P
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):433-45. PubMed ID: 24010938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase.
    Wang Z; Chen Z; Li J; Huang J; Zheng C; Liu JP
    J Biomol Struct Dyn; 2020 Mar; 38(4):1071-1082. PubMed ID: 30915896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
    Waikar MV; Hegde SS; Ford AP; Clarke DE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling of some 1H-benzimidazole derivatives with biological activity against Entamoeba histolytica: a comparative molecular field analysis study.
    López-Vallejo F; Medina-Franco JL; Hernández-Campos A; Rodríguez-Morales S; Yépez L; Cedillo R; Castillo R
    Bioorg Med Chem; 2007 Jan; 15(2):1117-26. PubMed ID: 17074492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. II. Synthesis and structure-activity relationships of 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Ohta M; Suzuki T; Ohmori J; Koide T; Matsuhisa A; Furuya T; Miyata K; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1996 May; 44(5):1000-8. PubMed ID: 8689715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
    Yan Y; Li Y; Zhang S; Ai C
    J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.